Literature DB >> 25758630

TNF-R1 as a first trimester marker for prediction of pre-eclampsia.

Sammya Bezerra Maia E Holanda Moura1,2,3, Felicity Park4, Padma Murthi5, Wellington P Martins6, Stefan C Kane3,7, Paul Williams4, Jonathan Hyett4,8, Fabrício da Silva Costa3,7,9.   

Abstract

OBJECTIVE: To examine whether the maternal serum concentration of the soluble receptor-1 of tumor necrosis factor-α (TNF-R1) at 11-13 + 6 weeks of gestation is a predictor of development of pre-eclampsia (PE).
METHODS: This is a nested case-control study in which the concentration of TNF-R1 at 11 + 0 to 13 + 6 weeks was measured in 426 pregnant women in the first trimester. TNF-R1 values were expressed as multiples of the median (MoM) adjusted for maternal factors. The distributions of log TNF-R1 MoM in the control group and hypertensive disorders (early-PE [ePE], late-PE [lPE] and gestational hypertension [GH]) groups were compared. Logistic regression analysis was used to determine whether maternal factors, TNF-R1 or their combination make a significant contribution to the prediction of PE. Screening performance was determined by analysis of receiver-operating characteristics curves.
RESULTS: Median concentration of TNF-R1 (ng/ml) was higher in ePE (2.62 ± 0.67), lPE (2.12 ± 0.56) and GH (2.19 ± 0.45) compared to controls (2.04 ± 0.42), p = 0.001. Logistic regression analysis demonstrated that the addition of TNFR-1 to maternal factors did not make a significant contribution to the prediction of PE.
CONCLUSIONS: The maternal serum TNF-R1 concentration at 11-13 + 6 weeks of gestation was increased in pregnancies which developed hypertensive disorders, however, the addition of TNFR-1 did not improve the detection rate of these conditions compared with maternal factors alone.

Entities:  

Keywords:  Biomarkers; hypertension; obstetrics; pregnancy; pregnancy-induced; screening

Mesh:

Substances:

Year:  2015        PMID: 25758630     DOI: 10.3109/14767058.2015.1022865

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  2 in total

Review 1.  Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review.

Authors:  Jaume Alijotas-Reig; Enrique Esteve-Valverde; Raquel Ferrer-Oliveras; Elisa Llurba; Josep Maria Gris
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

2.  External Validation Study of First Trimester Obstetric Prediction Models (Expect Study I): Research Protocol and Population Characteristics.

Authors:  Linda Jacqueline Elisabeth Meertens; Hubertina Cj Scheepers; Raymond G De Vries; Carmen D Dirksen; Irene Korstjens; Antonius Lm Mulder; Marianne J Nieuwenhuijze; Jan G Nijhuis; Marc Ea Spaanderman; Luc Jm Smits
Journal:  JMIR Res Protoc       Date:  2017-10-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.